Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Modulation of Cholinergic Function in Post-Menopausal Women and Alzheimer's Patients
NCT00006399Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Sep 1999
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of DehydraTECH-estrogen in Alzheimer's disease (AD) (2 arms), sponsored by National Center for Research Resources. Primary endpoint: Cognitive assessment after cholinergic antagonist challenge at 6 months. Started Sep 1999; status: completed.
02
Drugs
DehydraTECH-estrogen
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00006399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006399.